CN114790449A - Application of calcium-dependent protein kinase gene GhCPK4 in resisting verticillium wilt of plants - Google Patents
Application of calcium-dependent protein kinase gene GhCPK4 in resisting verticillium wilt of plants Download PDFInfo
- Publication number
- CN114790449A CN114790449A CN202210514664.4A CN202210514664A CN114790449A CN 114790449 A CN114790449 A CN 114790449A CN 202210514664 A CN202210514664 A CN 202210514664A CN 114790449 A CN114790449 A CN 114790449A
- Authority
- CN
- China
- Prior art keywords
- protein
- cotton
- verticillium wilt
- ghcpk4
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000082085 Verticillium <Phyllachorales> Species 0.000 title claims abstract description 65
- 108010025267 calcium-dependent protein kinase Proteins 0.000 title abstract description 9
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 99
- 241000196324 Embryophyta Species 0.000 claims abstract description 77
- 229920000742 Cotton Polymers 0.000 claims abstract description 69
- 244000299507 Gossypium hirsutum Species 0.000 claims abstract description 26
- 235000009429 Gossypium barbadense Nutrition 0.000 claims abstract description 19
- 235000018322 upland cotton Nutrition 0.000 claims abstract description 19
- 239000013604 expression vector Substances 0.000 claims abstract description 8
- 241000219146 Gossypium Species 0.000 claims description 67
- 230000014509 gene expression Effects 0.000 claims description 39
- 102000004169 proteins and genes Human genes 0.000 claims description 33
- 239000013598 vector Substances 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 20
- 230000030279 gene silencing Effects 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 10
- 108020004707 nucleic acids Proteins 0.000 claims description 10
- 102000039446 nucleic acids Human genes 0.000 claims description 10
- 150000007523 nucleic acids Chemical class 0.000 claims description 10
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 9
- 239000002773 nucleotide Substances 0.000 claims description 7
- 125000003729 nucleotide group Chemical group 0.000 claims description 7
- 230000001105 regulatory effect Effects 0.000 claims description 7
- 244000005700 microbiome Species 0.000 claims description 6
- 239000012620 biological material Substances 0.000 claims description 4
- 238000012217 deletion Methods 0.000 claims description 3
- 230000037430 deletion Effects 0.000 claims description 3
- 235000009438 Gossypium Nutrition 0.000 claims description 2
- 125000000539 amino acid group Chemical group 0.000 claims description 2
- 210000004899 c-terminal region Anatomy 0.000 claims description 2
- 230000001276 controlling effect Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 230000028604 virus induced gene silencing Effects 0.000 abstract description 20
- 201000010099 disease Diseases 0.000 abstract description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 19
- 238000011160 research Methods 0.000 abstract description 9
- 238000012216 screening Methods 0.000 abstract description 5
- 230000009261 transgenic effect Effects 0.000 abstract description 4
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 230000009456 molecular mechanism Effects 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 17
- 238000011529 RT qPCR Methods 0.000 description 17
- 238000004458 analytical method Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 12
- 241001123668 Verticillium dahliae Species 0.000 description 11
- 239000002299 complementary DNA Substances 0.000 description 10
- 230000035882 stress Effects 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 101150084750 1 gene Proteins 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 7
- 150000001413 amino acids Chemical group 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 238000011161 development Methods 0.000 description 7
- 238000012226 gene silencing method Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000012408 PCR amplification Methods 0.000 description 6
- ZNJFBWYDHIGLCU-HWKXXFMVSA-N jasmonic acid Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-HWKXXFMVSA-N 0.000 description 6
- 239000013612 plasmid Substances 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 238000010839 reverse transcription Methods 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 238000002791 soaking Methods 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 230000002792 vascular Effects 0.000 description 5
- 241000589158 Agrobacterium Species 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 108010034529 leucyl-lysine Proteins 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 238000003753 real-time PCR Methods 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 235000009432 Gossypium hirsutum Nutrition 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 108010005233 alanylglutamic acid Proteins 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000001976 enzyme digestion Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- ZNJFBWYDHIGLCU-UHFFFAOYSA-N jasmonic acid Natural products CCC=CCC1C(CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-UHFFFAOYSA-N 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 241000219195 Arabidopsis thaliana Species 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- WATXSTJXNBOHKD-LAEOZQHASA-N Glu-Asp-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O WATXSTJXNBOHKD-LAEOZQHASA-N 0.000 description 2
- VIPDPMHGICREIS-GVXVVHGQSA-N Glu-Val-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O VIPDPMHGICREIS-GVXVVHGQSA-N 0.000 description 2
- LHRXAHLCRMQBGJ-RYUDHWBXSA-N Gly-Glu-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CN LHRXAHLCRMQBGJ-RYUDHWBXSA-N 0.000 description 2
- 240000002024 Gossypium herbaceum Species 0.000 description 2
- 235000004341 Gossypium herbaceum Nutrition 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- AQTWDZDISVGCAC-CFMVVWHZSA-N Ile-Asp-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N AQTWDZDISVGCAC-CFMVVWHZSA-N 0.000 description 2
- 238000010802 RNA extraction kit Methods 0.000 description 2
- PVDTYLHUWAEYGY-CIUDSAMLSA-N Ser-Glu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PVDTYLHUWAEYGY-CIUDSAMLSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 108010047495 alanylglycine Proteins 0.000 description 2
- 108010013835 arginine glutamate Proteins 0.000 description 2
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 108010025306 histidylleucine Proteins 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 108010064235 lysylglycine Proteins 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000008054 signal transmission Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000009331 sowing Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- COEXAQSTZUWMRI-STQMWFEESA-N (2s)-1-[2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound C([C@H](N)C(=O)NCC(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=C(O)C=C1 COEXAQSTZUWMRI-STQMWFEESA-N 0.000 description 1
- AJPADPZSRRUGHI-RFZPGFLSSA-L 1-deoxy-D-xylulose 5-phosphate(2-) Chemical compound CC(=O)[C@@H](O)[C@H](O)COP([O-])([O-])=O AJPADPZSRRUGHI-RFZPGFLSSA-L 0.000 description 1
- DKJPOZOEBONHFS-ZLUOBGJFSA-N Ala-Ala-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O DKJPOZOEBONHFS-ZLUOBGJFSA-N 0.000 description 1
- DECCMEWNXSNSDO-ZLUOBGJFSA-N Ala-Cys-Ala Chemical compound C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O DECCMEWNXSNSDO-ZLUOBGJFSA-N 0.000 description 1
- XAGIMRPOEJSYER-CIUDSAMLSA-N Ala-Cys-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)N XAGIMRPOEJSYER-CIUDSAMLSA-N 0.000 description 1
- BTBUEVAGZCKULD-XPUUQOCRSA-N Ala-Gly-His Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 BTBUEVAGZCKULD-XPUUQOCRSA-N 0.000 description 1
- PCIFXPRIFWKWLK-YUMQZZPRSA-N Ala-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N PCIFXPRIFWKWLK-YUMQZZPRSA-N 0.000 description 1
- PEIBBAXIKUAYGN-UBHSHLNASA-N Ala-Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 PEIBBAXIKUAYGN-UBHSHLNASA-N 0.000 description 1
- MUGAESARFRGOTQ-IGNZVWTISA-N Ala-Tyr-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N MUGAESARFRGOTQ-IGNZVWTISA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 101100532087 Arabidopsis thaliana RUB2 gene Proteins 0.000 description 1
- UXJCMQFPDWCHKX-DCAQKATOSA-N Arg-Arg-Glu Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O UXJCMQFPDWCHKX-DCAQKATOSA-N 0.000 description 1
- IIABBYGHLYWVOS-FXQIFTODSA-N Arg-Asn-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O IIABBYGHLYWVOS-FXQIFTODSA-N 0.000 description 1
- OTCJMMRQBVDQRK-DCAQKATOSA-N Arg-Asp-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O OTCJMMRQBVDQRK-DCAQKATOSA-N 0.000 description 1
- GOWZVQXTHUCNSQ-NHCYSSNCSA-N Arg-Glu-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O GOWZVQXTHUCNSQ-NHCYSSNCSA-N 0.000 description 1
- RFXXUWGNVRJTNQ-QXEWZRGKSA-N Arg-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N RFXXUWGNVRJTNQ-QXEWZRGKSA-N 0.000 description 1
- CLICCYPMVFGUOF-IHRRRGAJSA-N Arg-Lys-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O CLICCYPMVFGUOF-IHRRRGAJSA-N 0.000 description 1
- JKRPBTQDPJSQIT-RCWTZXSCSA-N Arg-Thr-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O JKRPBTQDPJSQIT-RCWTZXSCSA-N 0.000 description 1
- UVTGNSWSRSCPLP-UHFFFAOYSA-N Arg-Tyr Natural products NC(CCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)O UVTGNSWSRSCPLP-UHFFFAOYSA-N 0.000 description 1
- VLIJAPRTSXSGFY-STQMWFEESA-N Arg-Tyr-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 VLIJAPRTSXSGFY-STQMWFEESA-N 0.000 description 1
- FMYQECOAIFGQGU-CYDGBPFRSA-N Arg-Val-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FMYQECOAIFGQGU-CYDGBPFRSA-N 0.000 description 1
- HZPSDHRYYIORKR-WHFBIAKZSA-N Asn-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O HZPSDHRYYIORKR-WHFBIAKZSA-N 0.000 description 1
- ACRYGQFHAQHDSF-ZLUOBGJFSA-N Asn-Asn-Asn Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ACRYGQFHAQHDSF-ZLUOBGJFSA-N 0.000 description 1
- QNJIRRVTOXNGMH-GUBZILKMSA-N Asn-Gln-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(N)=O QNJIRRVTOXNGMH-GUBZILKMSA-N 0.000 description 1
- OLISTMZJGQUOGS-GMOBBJLQSA-N Asn-Ile-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N OLISTMZJGQUOGS-GMOBBJLQSA-N 0.000 description 1
- HZZIFFOVHLWGCS-KKUMJFAQSA-N Asn-Phe-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O HZZIFFOVHLWGCS-KKUMJFAQSA-N 0.000 description 1
- IDUUACUJKUXKKD-VEVYYDQMSA-N Asn-Pro-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O IDUUACUJKUXKKD-VEVYYDQMSA-N 0.000 description 1
- AMGQTNHANMRPOE-LKXGYXEUSA-N Asn-Thr-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O AMGQTNHANMRPOE-LKXGYXEUSA-N 0.000 description 1
- HMQDRBKQMLRCCG-GMOBBJLQSA-N Asp-Arg-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HMQDRBKQMLRCCG-GMOBBJLQSA-N 0.000 description 1
- ATYWBXGNXZYZGI-ACZMJKKPSA-N Asp-Asn-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O ATYWBXGNXZYZGI-ACZMJKKPSA-N 0.000 description 1
- VPSHHQXIWLGVDD-ZLUOBGJFSA-N Asp-Asp-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O VPSHHQXIWLGVDD-ZLUOBGJFSA-N 0.000 description 1
- BKXPJCBEHWFSTF-ACZMJKKPSA-N Asp-Gln-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O BKXPJCBEHWFSTF-ACZMJKKPSA-N 0.000 description 1
- PDECQIHABNQRHN-GUBZILKMSA-N Asp-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(O)=O PDECQIHABNQRHN-GUBZILKMSA-N 0.000 description 1
- YNCHFVRXEQFPBY-BQBZGAKWSA-N Asp-Gly-Arg Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N YNCHFVRXEQFPBY-BQBZGAKWSA-N 0.000 description 1
- QHHVSXGWLYEAGX-GUBZILKMSA-N Asp-His-Gln Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N QHHVSXGWLYEAGX-GUBZILKMSA-N 0.000 description 1
- NHSDEZURHWEZPN-SXTJYALSSA-N Asp-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CC(=O)O)N NHSDEZURHWEZPN-SXTJYALSSA-N 0.000 description 1
- KFAFUJMGHVVYRC-DCAQKATOSA-N Asp-Leu-Met Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O KFAFUJMGHVVYRC-DCAQKATOSA-N 0.000 description 1
- MYOHQBFRJQFIDZ-KKUMJFAQSA-N Asp-Leu-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MYOHQBFRJQFIDZ-KKUMJFAQSA-N 0.000 description 1
- QJHOOKBAHRJPPX-QWRGUYRKSA-N Asp-Phe-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 QJHOOKBAHRJPPX-QWRGUYRKSA-N 0.000 description 1
- SXLCDCZHNCLFGZ-BPUTZDHNSA-N Asp-Pro-Trp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O SXLCDCZHNCLFGZ-BPUTZDHNSA-N 0.000 description 1
- 101150082449 CDPK4 gene Proteins 0.000 description 1
- 101150048466 CPK11 gene Proteins 0.000 description 1
- 101150058743 CPK4 gene Proteins 0.000 description 1
- 102100022789 Calcium/calmodulin-dependent protein kinase type IV Human genes 0.000 description 1
- 102000000584 Calmodulin Human genes 0.000 description 1
- 108010041952 Calmodulin Proteins 0.000 description 1
- WTNLLMQAFPOCTJ-GARJFASQSA-N Cys-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CS)N)C(=O)O WTNLLMQAFPOCTJ-GARJFASQSA-N 0.000 description 1
- NXQCSPVUPLUTJH-WHFBIAKZSA-N Cys-Ser-Gly Chemical compound SC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O NXQCSPVUPLUTJH-WHFBIAKZSA-N 0.000 description 1
- JLZCAZJGWNRXCI-XKBZYTNZSA-N Cys-Thr-Glu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O JLZCAZJGWNRXCI-XKBZYTNZSA-N 0.000 description 1
- 108010090461 DFG peptide Proteins 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- KVXVVDFOZNYYKZ-DCAQKATOSA-N Gln-Gln-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O KVXVVDFOZNYYKZ-DCAQKATOSA-N 0.000 description 1
- CLPQUWHBWXFJOX-BQBZGAKWSA-N Gln-Gly-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O CLPQUWHBWXFJOX-BQBZGAKWSA-N 0.000 description 1
- GNMQDOGFWYWPNM-LAEOZQHASA-N Gln-Gly-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)C(O)=O GNMQDOGFWYWPNM-LAEOZQHASA-N 0.000 description 1
- WZZSKAJIHTUUSG-ACZMJKKPSA-N Glu-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O WZZSKAJIHTUUSG-ACZMJKKPSA-N 0.000 description 1
- UTKICHUQEQBDGC-ACZMJKKPSA-N Glu-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N UTKICHUQEQBDGC-ACZMJKKPSA-N 0.000 description 1
- CKRUHITYRFNUKW-WDSKDSINSA-N Glu-Asn-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O CKRUHITYRFNUKW-WDSKDSINSA-N 0.000 description 1
- DRLVXRQFROIYTD-GUBZILKMSA-N Glu-His-Asn Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N DRLVXRQFROIYTD-GUBZILKMSA-N 0.000 description 1
- DVLZZEPUNFEUBW-AVGNSLFASA-N Glu-His-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)O)N DVLZZEPUNFEUBW-AVGNSLFASA-N 0.000 description 1
- ZWABFSSWTSAMQN-KBIXCLLPSA-N Glu-Ile-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O ZWABFSSWTSAMQN-KBIXCLLPSA-N 0.000 description 1
- QIQABBIDHGQXGA-ZPFDUUQYSA-N Glu-Ile-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O QIQABBIDHGQXGA-ZPFDUUQYSA-N 0.000 description 1
- XEKAJTCACGEBOK-KKUMJFAQSA-N Glu-Met-Phe Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCC(=O)O)N XEKAJTCACGEBOK-KKUMJFAQSA-N 0.000 description 1
- FGSGPLRPQCZBSQ-AVGNSLFASA-N Glu-Phe-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O FGSGPLRPQCZBSQ-AVGNSLFASA-N 0.000 description 1
- IDEODOAVGCMUQV-GUBZILKMSA-N Glu-Ser-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O IDEODOAVGCMUQV-GUBZILKMSA-N 0.000 description 1
- MWTGQXBHVRTCOR-GLLZPBPUSA-N Glu-Thr-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MWTGQXBHVRTCOR-GLLZPBPUSA-N 0.000 description 1
- GWCRIHNSVMOBEQ-BQBZGAKWSA-N Gly-Arg-Ser Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O GWCRIHNSVMOBEQ-BQBZGAKWSA-N 0.000 description 1
- QPDUVFSVVAOUHE-XVKPBYJWSA-N Gly-Gln-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CN)C(O)=O QPDUVFSVVAOUHE-XVKPBYJWSA-N 0.000 description 1
- YYPFZVIXAVDHIK-IUCAKERBSA-N Gly-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CN YYPFZVIXAVDHIK-IUCAKERBSA-N 0.000 description 1
- YNIMVVJTPWCUJH-KBPBESRZSA-N Gly-His-Tyr Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YNIMVVJTPWCUJH-KBPBESRZSA-N 0.000 description 1
- NSTUFLGQJCOCDL-UWVGGRQHSA-N Gly-Leu-Arg Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NSTUFLGQJCOCDL-UWVGGRQHSA-N 0.000 description 1
- WNGHUXFWEWTKAO-YUMQZZPRSA-N Gly-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN WNGHUXFWEWTKAO-YUMQZZPRSA-N 0.000 description 1
- ZVXMEWXHFBYJPI-LSJOCFKGSA-N Gly-Val-Ile Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZVXMEWXHFBYJPI-LSJOCFKGSA-N 0.000 description 1
- YGHSQRJSHKYUJY-SCZZXKLOSA-N Gly-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN YGHSQRJSHKYUJY-SCZZXKLOSA-N 0.000 description 1
- KSOBNUBCYHGUKH-UWVGGRQHSA-N Gly-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN KSOBNUBCYHGUKH-UWVGGRQHSA-N 0.000 description 1
- LBCAQRFTWMMWRR-CIUDSAMLSA-N His-Cys-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O LBCAQRFTWMMWRR-CIUDSAMLSA-N 0.000 description 1
- VTZYMXGGXOFBMX-DJFWLOJKSA-N His-Ile-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O VTZYMXGGXOFBMX-DJFWLOJKSA-N 0.000 description 1
- IWXMHXYOACDSIA-PYJNHQTQSA-N His-Ile-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O IWXMHXYOACDSIA-PYJNHQTQSA-N 0.000 description 1
- PZAJPILZRFPYJJ-SRVKXCTJSA-N His-Ser-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O PZAJPILZRFPYJJ-SRVKXCTJSA-N 0.000 description 1
- 101100287682 Homo sapiens CAMK2G gene Proteins 0.000 description 1
- 101100126883 Homo sapiens CAMK4 gene Proteins 0.000 description 1
- 101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- NKVZTQVGUNLLQW-JBDRJPRFSA-N Ile-Ala-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)N NKVZTQVGUNLLQW-JBDRJPRFSA-N 0.000 description 1
- YKRYHWJRQUSTKG-KBIXCLLPSA-N Ile-Ala-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N YKRYHWJRQUSTKG-KBIXCLLPSA-N 0.000 description 1
- YOTNPRLPIPHQSB-XUXIUFHCSA-N Ile-Arg-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N YOTNPRLPIPHQSB-XUXIUFHCSA-N 0.000 description 1
- BSWLQVGEVFYGIM-ZPFDUUQYSA-N Ile-Gln-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N BSWLQVGEVFYGIM-ZPFDUUQYSA-N 0.000 description 1
- DMZOUKXXHJQPTL-GRLWGSQLSA-N Ile-Gln-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N DMZOUKXXHJQPTL-GRLWGSQLSA-N 0.000 description 1
- NHJKZMDIMMTVCK-QXEWZRGKSA-N Ile-Gly-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N NHJKZMDIMMTVCK-QXEWZRGKSA-N 0.000 description 1
- QZZIBQZLWBOOJH-PEDHHIEDSA-N Ile-Ile-Val Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)O QZZIBQZLWBOOJH-PEDHHIEDSA-N 0.000 description 1
- RQJUKVXWAKJDBW-SVSWQMSJSA-N Ile-Ser-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N RQJUKVXWAKJDBW-SVSWQMSJSA-N 0.000 description 1
- WXLYNEHOGRYNFU-URLPEUOOSA-N Ile-Thr-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N WXLYNEHOGRYNFU-URLPEUOOSA-N 0.000 description 1
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 1
- 241000880493 Leptailurus serval Species 0.000 description 1
- POJPZSMTTMLSTG-SRVKXCTJSA-N Leu-Asn-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N POJPZSMTTMLSTG-SRVKXCTJSA-N 0.000 description 1
- KAFOIVJDVSZUMD-DCAQKATOSA-N Leu-Gln-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-DCAQKATOSA-N 0.000 description 1
- RVVBWTWPNFDYBE-SRVKXCTJSA-N Leu-Glu-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RVVBWTWPNFDYBE-SRVKXCTJSA-N 0.000 description 1
- KVOFSTUWVSQMDK-KKUMJFAQSA-N Leu-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)CC1=CN=CN1 KVOFSTUWVSQMDK-KKUMJFAQSA-N 0.000 description 1
- HRTRLSRYZZKPCO-BJDJZHNGSA-N Leu-Ile-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O HRTRLSRYZZKPCO-BJDJZHNGSA-N 0.000 description 1
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 1
- RXGLHDWAZQECBI-SRVKXCTJSA-N Leu-Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O RXGLHDWAZQECBI-SRVKXCTJSA-N 0.000 description 1
- REPBGZHJKYWFMJ-KKUMJFAQSA-N Leu-Lys-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N REPBGZHJKYWFMJ-KKUMJFAQSA-N 0.000 description 1
- KPYAOIVPJKPIOU-KKUMJFAQSA-N Leu-Lys-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O KPYAOIVPJKPIOU-KKUMJFAQSA-N 0.000 description 1
- SVBJIZVVYJYGLA-DCAQKATOSA-N Leu-Ser-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O SVBJIZVVYJYGLA-DCAQKATOSA-N 0.000 description 1
- DAYQSYGBCUKVKT-VOAKCMCISA-N Leu-Thr-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O DAYQSYGBCUKVKT-VOAKCMCISA-N 0.000 description 1
- ARNIBBOXIAWUOP-MGHWNKPDSA-N Leu-Tyr-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ARNIBBOXIAWUOP-MGHWNKPDSA-N 0.000 description 1
- VQHUBNVKFFLWRP-ULQDDVLXSA-N Leu-Tyr-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=C(O)C=C1 VQHUBNVKFFLWRP-ULQDDVLXSA-N 0.000 description 1
- XZNJZXJZBMBGGS-NHCYSSNCSA-N Leu-Val-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O XZNJZXJZBMBGGS-NHCYSSNCSA-N 0.000 description 1
- FZIJIFCXUCZHOL-CIUDSAMLSA-N Lys-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN FZIJIFCXUCZHOL-CIUDSAMLSA-N 0.000 description 1
- NFLFJGGKOHYZJF-BJDJZHNGSA-N Lys-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN NFLFJGGKOHYZJF-BJDJZHNGSA-N 0.000 description 1
- SJNZALDHDUYDBU-IHRRRGAJSA-N Lys-Arg-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(O)=O SJNZALDHDUYDBU-IHRRRGAJSA-N 0.000 description 1
- DEFGUIIUYAUEDU-ZPFDUUQYSA-N Lys-Asn-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DEFGUIIUYAUEDU-ZPFDUUQYSA-N 0.000 description 1
- AAORVPFVUIHEAB-YUMQZZPRSA-N Lys-Asp-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O AAORVPFVUIHEAB-YUMQZZPRSA-N 0.000 description 1
- IWWMPCPLFXFBAF-SRVKXCTJSA-N Lys-Asp-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O IWWMPCPLFXFBAF-SRVKXCTJSA-N 0.000 description 1
- KWUKZRFFKPLUPE-HJGDQZAQSA-N Lys-Asp-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KWUKZRFFKPLUPE-HJGDQZAQSA-N 0.000 description 1
- WGLAORUKDGRINI-WDCWCFNPSA-N Lys-Glu-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGLAORUKDGRINI-WDCWCFNPSA-N 0.000 description 1
- ITWQLSZTLBKWJM-YUMQZZPRSA-N Lys-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCCCN ITWQLSZTLBKWJM-YUMQZZPRSA-N 0.000 description 1
- NKKFVJRLCCUJNA-QWRGUYRKSA-N Lys-Gly-Lys Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN NKKFVJRLCCUJNA-QWRGUYRKSA-N 0.000 description 1
- ALGGDNMLQNFVIZ-SRVKXCTJSA-N Lys-Lys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N ALGGDNMLQNFVIZ-SRVKXCTJSA-N 0.000 description 1
- CNGOEHJCLVCJHN-SRVKXCTJSA-N Lys-Pro-Glu Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O CNGOEHJCLVCJHN-SRVKXCTJSA-N 0.000 description 1
- BDFHWFUAQLIMJO-KXNHARMFSA-N Lys-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N)O BDFHWFUAQLIMJO-KXNHARMFSA-N 0.000 description 1
- 244000237986 Melia azadirachta Species 0.000 description 1
- QEVRUYFHWJJUHZ-DCAQKATOSA-N Met-Ala-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(C)C QEVRUYFHWJJUHZ-DCAQKATOSA-N 0.000 description 1
- DRXODWRPPUFIAY-DCAQKATOSA-N Met-Asn-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCCN DRXODWRPPUFIAY-DCAQKATOSA-N 0.000 description 1
- NCVJJAJVWILAGI-SRVKXCTJSA-N Met-Gln-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N NCVJJAJVWILAGI-SRVKXCTJSA-N 0.000 description 1
- SJDQOYTYNGZZJX-SRVKXCTJSA-N Met-Glu-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O SJDQOYTYNGZZJX-SRVKXCTJSA-N 0.000 description 1
- WWWGMQHQSAUXBU-BQBZGAKWSA-N Met-Gly-Asn Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(N)=O WWWGMQHQSAUXBU-BQBZGAKWSA-N 0.000 description 1
- RXWPLVRJQNWXRQ-IHRRRGAJSA-N Met-His-His Chemical compound C([C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)C1=CNC=N1 RXWPLVRJQNWXRQ-IHRRRGAJSA-N 0.000 description 1
- RBGLBUDVQVPTEG-DCAQKATOSA-N Met-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCSC)N RBGLBUDVQVPTEG-DCAQKATOSA-N 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 101100327381 Oryza sativa subsp. japonica CPK7 gene Proteins 0.000 description 1
- LDSOBEJVGGVWGD-DLOVCJGASA-N Phe-Asp-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 LDSOBEJVGGVWGD-DLOVCJGASA-N 0.000 description 1
- OJUMUUXGSXUZJZ-SRVKXCTJSA-N Phe-Asp-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O OJUMUUXGSXUZJZ-SRVKXCTJSA-N 0.000 description 1
- QPVFUAUFEBPIPT-CDMKHQONSA-N Phe-Gly-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O QPVFUAUFEBPIPT-CDMKHQONSA-N 0.000 description 1
- BNRFQGLWLQESBG-YESZJQIVSA-N Phe-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O BNRFQGLWLQESBG-YESZJQIVSA-N 0.000 description 1
- AFNJAQVMTIQTCB-DLOVCJGASA-N Phe-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=CC=C1 AFNJAQVMTIQTCB-DLOVCJGASA-N 0.000 description 1
- UNBFGVQVQGXXCK-KKUMJFAQSA-N Phe-Ser-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O UNBFGVQVQGXXCK-KKUMJFAQSA-N 0.000 description 1
- RAGOJJCBGXARPO-XVSYOHENSA-N Phe-Thr-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 RAGOJJCBGXARPO-XVSYOHENSA-N 0.000 description 1
- BPIFSOUEUYDJRM-DCPHZVHLSA-N Phe-Trp-Ala Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](C)C(O)=O)C1=CC=CC=C1 BPIFSOUEUYDJRM-DCPHZVHLSA-N 0.000 description 1
- 108020005089 Plant RNA Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- BRJGUPWVFXKBQI-XUXIUFHCSA-N Pro-Leu-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BRJGUPWVFXKBQI-XUXIUFHCSA-N 0.000 description 1
- ZLXKLMHAMDENIO-DCAQKATOSA-N Pro-Lys-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLXKLMHAMDENIO-DCAQKATOSA-N 0.000 description 1
- OQSGBXGNAFQGGS-CYDGBPFRSA-N Pro-Val-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O OQSGBXGNAFQGGS-CYDGBPFRSA-N 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- FCRMLGJMPXCAHD-FXQIFTODSA-N Ser-Arg-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O FCRMLGJMPXCAHD-FXQIFTODSA-N 0.000 description 1
- NRCJWSGXMAPYQX-LPEHRKFASA-N Ser-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)N)C(=O)O NRCJWSGXMAPYQX-LPEHRKFASA-N 0.000 description 1
- MMAPOBOTRUVNKJ-ZLUOBGJFSA-N Ser-Asp-Ser Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CO)N)C(=O)O MMAPOBOTRUVNKJ-ZLUOBGJFSA-N 0.000 description 1
- UOLGINIHBRIECN-FXQIFTODSA-N Ser-Glu-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UOLGINIHBRIECN-FXQIFTODSA-N 0.000 description 1
- UQFYNFTYDHUIMI-WHFBIAKZSA-N Ser-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CO UQFYNFTYDHUIMI-WHFBIAKZSA-N 0.000 description 1
- SFTZWNJFZYOLBD-ZDLURKLDSA-N Ser-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO SFTZWNJFZYOLBD-ZDLURKLDSA-N 0.000 description 1
- UIPXCLNLUUAMJU-JBDRJPRFSA-N Ser-Ile-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O UIPXCLNLUUAMJU-JBDRJPRFSA-N 0.000 description 1
- KJKQUQXDEKMPDK-FXQIFTODSA-N Ser-Met-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(O)=O KJKQUQXDEKMPDK-FXQIFTODSA-N 0.000 description 1
- AZWNCEBQZXELEZ-FXQIFTODSA-N Ser-Pro-Ser Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O AZWNCEBQZXELEZ-FXQIFTODSA-N 0.000 description 1
- XGQKSRGHEZNWIS-IHRRRGAJSA-N Ser-Pro-Tyr Chemical compound N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O XGQKSRGHEZNWIS-IHRRRGAJSA-N 0.000 description 1
- NADLKBTYNKUJEP-KATARQTJSA-N Ser-Thr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NADLKBTYNKUJEP-KATARQTJSA-N 0.000 description 1
- 102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- STGXWWBXWXZOER-MBLNEYKQSA-N Thr-Ala-His Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 STGXWWBXWXZOER-MBLNEYKQSA-N 0.000 description 1
- MFEBUIFJVPNZLO-OLHMAJIHSA-N Thr-Asp-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O MFEBUIFJVPNZLO-OLHMAJIHSA-N 0.000 description 1
- DCLBXIWHLVEPMQ-JRQIVUDYSA-N Thr-Asp-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 DCLBXIWHLVEPMQ-JRQIVUDYSA-N 0.000 description 1
- ZUUDNCOCILSYAM-KKHAAJSZSA-N Thr-Asp-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O ZUUDNCOCILSYAM-KKHAAJSZSA-N 0.000 description 1
- NRUPKQSXTJNQGD-XGEHTFHBSA-N Thr-Cys-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NRUPKQSXTJNQGD-XGEHTFHBSA-N 0.000 description 1
- LKEKWDJCJSPXNI-IRIUXVKKSA-N Thr-Glu-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 LKEKWDJCJSPXNI-IRIUXVKKSA-N 0.000 description 1
- UDNVOQMPQBEITB-MEYUZBJRSA-N Thr-His-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O UDNVOQMPQBEITB-MEYUZBJRSA-N 0.000 description 1
- IMDMLDSVUSMAEJ-HJGDQZAQSA-N Thr-Leu-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O IMDMLDSVUSMAEJ-HJGDQZAQSA-N 0.000 description 1
- RFKVQLIXNVEOMB-WEDXCCLWSA-N Thr-Leu-Gly Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N)O RFKVQLIXNVEOMB-WEDXCCLWSA-N 0.000 description 1
- OHDXOXIZXSFCDN-RCWTZXSCSA-N Thr-Met-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OHDXOXIZXSFCDN-RCWTZXSCSA-N 0.000 description 1
- COYHRQWNJDJCNA-NUJDXYNKSA-N Thr-Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O COYHRQWNJDJCNA-NUJDXYNKSA-N 0.000 description 1
- JAWUQFCGNVEDRN-MEYUZBJRSA-N Thr-Tyr-Leu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N)O JAWUQFCGNVEDRN-MEYUZBJRSA-N 0.000 description 1
- CURFABYITJVKEW-QTKMDUPCSA-N Thr-Val-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O CURFABYITJVKEW-QTKMDUPCSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- BONYBFXWMXBAND-GQGQLFGLSA-N Trp-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N BONYBFXWMXBAND-GQGQLFGLSA-N 0.000 description 1
- YCQXZDHDSUHUSG-FJHTZYQYSA-N Trp-Thr-Ala Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O)=CNC2=C1 YCQXZDHDSUHUSG-FJHTZYQYSA-N 0.000 description 1
- HKYTWJOWZTWBQB-AVGNSLFASA-N Tyr-Glu-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 HKYTWJOWZTWBQB-AVGNSLFASA-N 0.000 description 1
- BXPOOVDVGWEXDU-WZLNRYEVSA-N Tyr-Ile-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BXPOOVDVGWEXDU-WZLNRYEVSA-N 0.000 description 1
- LMKKMCGTDANZTR-BZSNNMDCSA-N Tyr-Phe-Asp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LMKKMCGTDANZTR-BZSNNMDCSA-N 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- SMKXLHVZIFKQRB-GUBZILKMSA-N Val-Ala-Met Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](C(C)C)N SMKXLHVZIFKQRB-GUBZILKMSA-N 0.000 description 1
- ZLFHAAGHGQBQQN-AEJSXWLSSA-N Val-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N ZLFHAAGHGQBQQN-AEJSXWLSSA-N 0.000 description 1
- ZLFHAAGHGQBQQN-GUBZILKMSA-N Val-Ala-Pro Natural products CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O ZLFHAAGHGQBQQN-GUBZILKMSA-N 0.000 description 1
- LIQJSDDOULTANC-QSFUFRPTSA-N Val-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)N LIQJSDDOULTANC-QSFUFRPTSA-N 0.000 description 1
- CGGVNFJRZJUVAE-BYULHYEWSA-N Val-Asp-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N CGGVNFJRZJUVAE-BYULHYEWSA-N 0.000 description 1
- VLOYGOZDPGYWFO-LAEOZQHASA-N Val-Asp-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VLOYGOZDPGYWFO-LAEOZQHASA-N 0.000 description 1
- UMPVMAYCLYMYGA-ONGXEEELSA-N Val-Leu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O UMPVMAYCLYMYGA-ONGXEEELSA-N 0.000 description 1
- AEMPCGRFEZTWIF-IHRRRGAJSA-N Val-Leu-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O AEMPCGRFEZTWIF-IHRRRGAJSA-N 0.000 description 1
- SBJCTAZFSZXWSR-AVGNSLFASA-N Val-Met-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N SBJCTAZFSZXWSR-AVGNSLFASA-N 0.000 description 1
- WUFHZIRMAZZWRS-OSUNSFLBSA-N Val-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C(C)C)N WUFHZIRMAZZWRS-OSUNSFLBSA-N 0.000 description 1
- AEFJNECXZCODJM-UWVGGRQHSA-N Val-Val-Gly Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](C(C)C)C(=O)NCC([O-])=O AEFJNECXZCODJM-UWVGGRQHSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000036579 abiotic stress Effects 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 108010092854 aspartyllysine Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000013211 curve analysis Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 108010090037 glycyl-alanyl-isoleucine Proteins 0.000 description 1
- 108010079413 glycyl-prolyl-glutamic acid Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 108010090333 leucyl-lysyl-proline Proteins 0.000 description 1
- 108010000761 leucylarginine Proteins 0.000 description 1
- 108010009298 lysylglutamic acid Proteins 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 108010085203 methionylmethionine Proteins 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011027 product recovery Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 108010077112 prolyl-proline Proteins 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008261 resistance mechanism Effects 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 230000008653 root damage Effects 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000001743 silencing effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 108010033670 threonyl-aspartyl-tyrosine Proteins 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 108010084932 tryptophyl-proline Proteins 0.000 description 1
- 108010079202 tyrosyl-alanyl-cysteine Proteins 0.000 description 1
- 108010003137 tyrosyltyrosine Proteins 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/11—Protein-serine/threonine kinases (2.7.11)
- C12Y207/11017—Ca2+/Calmodulin-dependent protein kinase (2.7.11.17)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses an application of a calcium-dependent protein kinase gene GhCPK4 in plant verticillium wilt resistance, and relates to the technical field of genetic engineering. The invention utilizes GhCPK4 gene to construct VIGS plant expression vector to transform upland cotton TM-1, and the obtained transgenic cotton shows resistance to verticillium wilt after being inoculated with cotton verticillium wilt V991, which shows that GhCPK4 gene is highly related to resistance to cotton verticillium wilt. The invention lays an application foundation for the research of the molecular mechanism of verticillium wilt resistance and the cultivation of new varieties of new verticillium wilt resistant plants, and simultaneously provides new reference for the screening of new disease-resistant genes and the cultivation of resistant plants.
Description
Technical Field
The invention relates to the technical field of genetic engineering, in particular to application of a calcium-dependent protein kinase gene in plant verticillium wilt resistance.
Background
The Verticillium wilt of cotton is mainly caused by Verticillium dahliae (Verticillium dahliae), and the pathogenic bacteria can be used as soil-borne fungi to contaminate the cotton in the whole growth period of the cotton, so that the cotton leaves are green and yellow, wilted, withered and shed, plants are short, cotton bolls are small and the like, even the cotton is dead, and the yield, the quality and the economic benefit of cotton planting are seriously affected. Due to the irreversibility of verticillium wilt, it is called "cancer" of cotton. Therefore, the method is particularly urgent for breeding new varieties of cotton upland cotton with verticillium wilt resistance. Due to the complexity of the pathogenic mechanism of cotton verticillium wilt and the difficulty and long period of screening disease-resistant varieties by the traditional hybridization method, upland cotton cultivars with excellent resistance to cotton verticillium wilt are not cultivated at present. The molecular improvement of cotton for resisting the verticillium wilt has become an urgent need for the continuous development of high-quality cotton bases. The development of the disease-resistant related genes of cotton to analyze the disease-resistant mechanism and the creation of new resistant germplasm by using transgenosis has become an important means for cotton verticillium wilt resistance breeding.
During the evolution process, plants form a series of complex signal transmission mechanisms to respond to stresses such as diseases, low temperature, drought, salt damage and the like, so that the environmental adaptability of the plants is improved, and damages caused by adversity are reduced to the greatest extent. Ca 2+ Is a second messenger commonly existing in plant cells and is widely involved in the growth and development, environmental response, stress response and the like of plantsAnd (6) processing. The calcium-dependent protein kinase CPKs (CPKs) are one of the first calcium-dependent protein kinases found in plants, belong to serine/threonine kinases, and can sense Ca in plant cells 2+ The concentration change is specifically combined with specific target cells, can be directly activated by calcium signals without the action of calmodulin, and plays an important role in regulating the growth and development of plants and adapting to the stress.
CPKs are encoded by multiple genes in plants and are involved in regulating plant responses to various environmental stresses (Chen et al, 2021). High temperature, drought, salt stress, exogenous hormone treatment and pathogenic microorganism infection can all cause the expression of CPKs gene by Ca 2+ Further regulating the response of the plant to various abiotic stress signals so as to resist the stress and enhance the stress resistance of the plant (Atif et al, 2019; Zhang et al, 2018). With the completion of cotton sequencing work, 41 CPKs genes have been identified from the diploid cotton Gossypium raimonidii genome, and 98 predicted CPKs among them were identified from upland cotton TM-1, with widely distributed CPKs expression in different organs, 19 of which respond rapidly to salt stress at the transcriptional level, and silencing of GhCPK8, GhCPK38, GhCPK54 and GhCPK55 severely affected cotton salt tolerance (Gao et al, 2018). The GhCPK 1gene is involved in regulating cotton fiber development (Huang et al, 2008; Wang et al, 2011). The GhCPK4 gene is involved positively in responding to drought and salt stress (Hu et al, 2019; margosa et al, 2022). The GhCPK5 gene is possibly located in a cell nucleus, can respond to the induction of salt stress and plays a role in a salt stress signal transduction pathway (screening military waves and the like, 2011). Since the calcium-dependent protein kinase is Ca 2+ An important component in the signal transmission pathway, and therefore, the identification of the calcium-dependent protein gene and the functional research thereof have important significance on the role of the calcium-dependent protein gene in the growth and development of plants and the response of the plants to environmental stimuli.
Disclosure of Invention
In view of the above, the invention provides the application of the calcium-dependent protein kinase gene GhCPK4 in the plant verticillium wilt resistance, and lays an application foundation for the cultivation of a new verticillium wilt-resistant cotton variety.
In order to achieve the purpose, the invention adopts the following technical scheme:
the application of protein or substance for regulating and controlling the expression of the protein coding gene in plant verticillium wilt resistance, wherein the amino acid sequence of the protein is shown as SEQ ID NO: 2 is shown in the specification;
or in the SEQ ID NO: 2 linked with protein tags at the N terminal and/or the C terminal of the amino acid sequence shown in the sequence table;
or the sequence of SEQ ID NO: 2 by substitution and/or deletion and/or addition of more than one amino acid residue, and obtaining the protein with the same function.
Preferably, the protein is derived from cotton.
Another object of the present invention is to provide the use of the protein-related biomaterial as described above for plant verticillium wilt resistance, wherein the protein-related biomaterial is any one of the following materials:
a: a nucleic acid molecule encoding the protein of claim 1;
b: an expression cassette comprising silencing of the nucleic acid molecule of A;
c: an expression vector containing the nucleic acid molecule of A or a recombinant vector containing the expression cassette of B;
d: a recombinant microorganism comprising the nucleic acid molecule described in A, or a recombinant microorganism comprising the expression cassette described in B, or a recombinant microorganism comprising the recombinant vector described in C.
The term "expression cassette" refers to a DNA capable of expressing a protein as described in the above application in a host cell, and the DNA may include not only a promoter for initiating the transcription of the protein-encoding gene but also a terminator for terminating the transcription of the protein-encoding gene. Further, the expression cassette may also include an enhancer sequence.
Preferably, the nucleotide sequence of the nucleic acid molecule is as shown in SEQ ID NO: 1 is shown in the specification;
or with said SEQ ID NO: 1 nucleotide sequence having a homology of 90% or more and encoding the protein of claim 1.
Preferably, the plant is any one of:
a: a plant of the genus gossypium; b: cotton; c: and (3) upland cotton TM-1.
It is still another object of the present invention to provide a method for improving verticillium wilt resistance in plants by silencing or inhibiting the expression level of a gene encoding the protein or the activity of the protein in plants.
The silencing or suppressing of the expression level of the protein-encoding gene in the plant can be achieved by any means known in the art, such as deletion mutation, insertion mutation or base change mutation of the gene, thereby achieving the reduction or loss of the function of the gene.
Preferably, the amino acid sequence of the protein is as shown in SEQ ID NO: 2, respectively.
Preferably, the nucleotide sequence of the coding gene of the protein is shown in SEQ ID NO: 1 is shown.
According to the technical scheme, compared with the prior art, the gene is amplified by utilizing the sequence information of the GhCPK4 gene, the VIGS plant expression vector is constructed to transform upland cotton TM-1, and the obtained transgenic cotton shows the resistance to verticillium wilt after being inoculated with cotton verticillium wilt bacteria V991, so that the GhCPK4 gene is highly related to the resistance to cotton verticillium wilt. The invention lays an application foundation for the research of molecular mechanism of verticillium wilt resistance and the cultivation of new varieties of new verticillium wilt resistant plants, and simultaneously provides new reference for the screening of new disease-resistant genes and the cultivation of resistant plants.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, it is obvious that the drawings in the following description are only embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to the provided drawings without creative efforts.
FIG. 1 is a diagram showing an electrophoresis diagram of a PCR product of the GhCPK4 gene in example 1 of the present invention, wherein the Marker is a 2000bp Ladder Marker;
FIG. 2 is a diagram showing an evolutionary tree of CPK related gene families;
FIG. 3 shows the qRT-PCR results of GhCPK4 gene expression level in different cotton tissues (leaf, root, stem, petal, sepal, and developing 5d fiber);
FIG. 4 shows signal molecules (jasmonic acid JA, salicylic acid SA, H) 2 O 2 Dip dyeing) induction condition of qRT-PCR result of the expression amount of the GhCPK4 gene;
FIG. 5 shows the qRT-PCR analysis result of expression pattern of GhCPK4 gene induced by verticillium dahliae V991;
FIG. 6 is a table of the plant phenotype of Gossypium hirsutum TM-1 after injection of VIGS vector, wherein: a is the phenotype of the plant after 2 weeks of injecting the VIGS vector of the GhCLA1 gene; b is TRV:00 (control) of upland cotton TM-1 and TRV: GhCPK4 inoculated with verticillium dahliae V991 spore liquid (10) by root dipping method 7 conidia/mL) disease incidence for 21 days;
FIG. 7 shows the qRT-PCR results of the expression level of the GhCPK4 gene in the leaf blade of upland cotton TM-1 at the three-leaf stage of the plant TRV:00 and TRV: GhCPK 4;
FIG. 8 is the result of statistics of disease index after transgenic upland cotton TM-1 is inoculated with Verticillium dahliae;
FIG. 9 is a longitudinal cut of cotton stalks of the default and control plants of VIGS-interfered upland cotton TM-1 plants for resistance analysis of verticillium wilt;
FIG. 10 is a graph showing the results of a fungus recovery experiment conducted on silenced plants of VIGS interference upland cotton TM-1 plants with stem segments sterilized on the surface of control plants;
FIG. 11 is a graph showing the statistical results of the cotton verticillium wilt recovery rate of silenced plants and control plants of VIGS interference upland cotton TM-1 plants for resistance analysis of verticillium wilt;
FIG. 12 is the relative abundance of Verticillium oxysporum DNA of the silenced plant and a control plant of VIGS interference upland cotton TM-1 plant for resistance analysis of Verticillium oxysporum.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be obtained by a person skilled in the art without making any creative effort based on the embodiments in the present invention, belong to the protection scope of the present invention.
The cotton material comprises:
upland cotton TM-1, provided by Cotton research institute of Chinese academy of agricultural sciences;
plant VIGS silencing expression vector:
verticillium wilt V991: the laboratory is reserved, and the public can obtain the laboratory from the Nuclear biotechnological research institute of agricultural academy of sciences (the biotechnological research center of Uygur autonomous region of Xinjiang);
the primer sequence is as follows: are all provided by Shanghai biological synthesis;
other biological materials include: escherichia coli strain DH5 alpha, agrobacterium strain GV3101, BP reaction entry vector, VIGS interference technology vector pTRV1 and pTRV2 and the like belong to commercial strains or vectors and are not described again;
experimental reagent: the plasmid extraction kit, oligo (dT)18, an RNAase inhibitor, dNTP, pMD18-T Vector, T4-DNA ligase, endonucleases EcoRI and KpnI, ExTaq enzyme, a PCR product recovery kit and the like are all products of TaKaRa company, and the fluorescent quantitative PCR kit is a product of TOYOBO company;
the special fluorescent quantitative PCR plate is a product of Labwards company;
RNA extraction kits were purchased from TIANGEN (Beijing, China);
the culture media and solutions used were: LB liquid (solid) medium, YEP liquid (solid) medium, Czapek's (Czapek) medium, PDA medium, 50 XTAE Buffer (Na) 2 EDTA·2H 2 37.2g of O, 57.1mL of glacial acetic acid, pH value adjusted by NaOH to be 8.3, and water is added to reach a constant volume of 1L), and the like, and the preparation method is conventional in the field;
other undescribed antibiotics, hormones and other reagents are common in the field and are not described in detail.
Example 1
1. Acquisition of Gossypium hirsutum GhCPK4 gene
Planting upland cotton TM-1, extracting RNA of cotton seedling leaves, and performing reverse transcription to obtain cDNA;
in the RNA extraction step, a TIANGEN plant RNA rapid extraction kit is referred, and a reverse transcription system is as follows:
executing the program: 30min at 42 ℃ and 5s at 85 ℃.
A cDNA (complementary deoxyribonucleic acid) with an ID number of a gene Gh _ A03G1505.1 (a nucleotide sequence is shown as SEQ ID NO: 1, and an amino acid sequence is shown as SEQ ID NO: 2) in a cottonFGD website (https:// CottonFGD. org) is used as a template, a primer is designed, and the gene is amplified, wherein the primer sequence is as follows:
GhCPK4-F:5’-GGGGTACCATGGGCAATACATGCCGTG-3’,SEQ ID NO:3;
GhCPK4-R:5’-GCTCTAGATTACATAGCACCTGGGGCA-3’,SEQ ID NO:4。
the PCR amplification system is as follows:
PCR amplification procedure: 2min at 95 ℃; 35 cycles of 95 ℃ for 20s, 52 ℃ for 30s, 72 ℃ for 30 s; 5min at 72 ℃.
The PCR products were detected by electrophoresis on 1% agarose gel, and the results are shown in FIG. 1. As can be seen from the figure, the size of the gene GhCPK4 is 1707 bp.
2. Biological information analysis of GhCPK4 gene
The physicochemical properties of the GhCPK4 protein were analyzed by an online website (http:// web. expasy. org/protparam /), and the protein contained 568 amino acids, had a molecular weight of 63.5kD, and had an isoelectric point pI of 5.81.
The obtained sequence is used for carrying out online sequence alignment at NCBI website, and the GhCPK4 protein belongs to the STKc _ CAMK protein family. The secondary structure of the GhCPK4 protein was predicted using an online site (http:// ffas. burn. org/Xtal Pred-cgi), and it was found that about 42% of the amino acids formed α -helices and 10% of the amino acids formed β -pleated sheets.
The result of the evolutionary tree analysis of GhCPK4 and the CPK family in Arabidopsis thaliana, maize, rice, tobacco and wheat is shown in figure 2, and the GhCPK4 has the closest genetic distance with the CPK4 and the CPK11 of Arabidopsis thaliana in the evolutionary relationship.
Example 2
1. Tissue expression pattern of GhCPK4 gene under natural condition
Respectively taking leaves, roots, stems, flowers, sepals and fibers developing for 5d from cotton in the full-bloom stage of the cotton, extracting RNA of the fibers, obtaining cDNA by using a reverse transcription kit, and carrying out qPCR amplification by adopting the following quantitative PCR primers:
QRT-PCR-GhCPK4F:5’-GTTAACAAGGATGATGATTTC-3’,SEQ ID NO:5;
QRT-PCR-GhCPK4R:5’-GCTATTACCCGTAAAGCCAT-3’,SEQ ID NO:6;
the reference gene selects Ubiquitin protein 7(Ubiquitin7, UB7), and the primer sequence is designed as follows:
UBQ7F:5’-GAAGGCATTCCACCTGACCAAC-3’,SEQ ID NO:7;
UBQ7R:5’-CTTGACCTTCTTCTTCTTGTGCTTG-3’,SEQ ID NO:8。
qRT-PCR was performed on ABI 7500Real-time PCR sequence detection system and software (Applied Biosystems, USA);
the 20 μ L reaction system was designed as follows:
the reaction system was 10. mu.L LSYBR Green Realtime PCR Master Mix, 1. mu.L cDNA product, 0.4. mu.L (10. mu.M) of each of the upstream and downstream primers, and nucleic-free Water was supplemented to a total reaction volume of 20. mu.L. There were 4 technical replicates per gene.
The corresponding procedure was a quantification procedure at 94 ℃ for 30 s; 95 ℃ for 5s, 57 ℃ for 15s, 72 ℃ for 31s, 40 cycles.
The specificity of the amplified products after 40 cycles was detected by a dissolution curve analysis. Each reaction included at least three replicates. The primers were tested for amplification efficiency by plotting the log value of the dilution of the template against the Ct value of each diluted sample using a single template diluted to different concentrations.
The detection result is shown in figure 3, and the analysis shows that the GhCPK4 gene is expressed in all tissues of cotton, but the transcription level is significantly different, wherein the expression of the gene in the flower is higher than that of other tissues, and sepals are arranged in the second; expression levels in leaves, roots, stems and developing 5d fibers were significantly lower than other tissues, with transcript levels in roots slightly higher than those in leaves, stems and developing 5d fibers.
2. Stressed by signal molecules (jasmonic acid JA, salicylic acid SA, H) 2 O 2 Dip-dyeing) of the gene GhCPK4
Soaking TM-1 cotton seeds in water for 24h, sowing in nutrient soil, and culturing under illumination at 26-28 deg.C for 12h in light/12 h in dark. Maintaining humidity at 60% or above, watering once for 4-5d, selecting cotton seedling with uniform growth and size when two leaves and one heart of seedling are planted, and respectively adding 200 μ M jasmonic acid, 2mM salicylic acid, and 1mM H 2 O 2 Soaking cotton seedling root system for 10min, and then continuously planting the cotton seedling in the nutrition pot. And respectively taking cotton roots at 0.5h, 1h, 3h and other time points after treatment, extracting RNA, and performing reverse transcription to obtain cDNA for expression pattern analysis.
The primer and PCR reaction procedure for qRT-PCR analysis were the same as in section 1 of this example, "tissue expression pattern of the natural GhCPK 4".
The detection result of qRT-PCR is shown in figure 4, the expression level of GhCPK4 is highest when the JA is treated for 1h and then is reduced; expression level of GhCPK4 in SA and H 2 O 2 The treatment trend is downward. The expression level of GhCPK4 is shown to be influenced by signal molecule stress.
3. Expression pattern of GhCPK4 under verticillium wilt pathogen infection condition
Selecting upland cotton TM-1 with two leaves and one heart, and using verticillium dahliae V991 conidium solution with concentration of 1 × 10 7 spores/mL, water treatment as a negative control. Soaking cotton seedling root in the bacterial liquid for 10min, planting in nutrition bowl, and taking cotton at time points of 0h, 0.5h, 2h, 6h, 12h, 24h, 48h, etc. after inoculationRoot system, extracting RNA and reverse transcribing cDNA for expression pattern analysis.
The primer and PCR reaction procedure for qRT-PCR analysis were the same as in section 1 of this example, "tissue expression pattern of the natural GhCPK 4".
The detection result of qRT-PCR is shown in figure 5, after V991 conidium liquid and water are treated, the expression level of GhCPK4 is significantly reduced after 12h of inoculation of verticillium wilt pathogenic bacteria, and the expression level tends to be lowest after 48 h. The result shows that the expression quantity of the gene GhCPK4 is obviously changed after the root system of the TM-1 is infected by verticillium dahliae.
Example 3
VIGS interference vector is constructed by using VIGS technology, so that the gene GhCPK4 is silenced. The phenotypic change of cotton infected with verticillium dahliae after gene precipitation is observed, and the gene GhCPK4 is further proved to be highly related to verticillium wilt resistance.
1. Construction of recombinant expression vectors
(1) Primer design and PCR amplification
Designing a primer in a non-conservative section of the gene GhCPK4, wherein the design principle of the primer is as follows: adding a restriction site and a protection base of a restriction enzyme EcoRI to an upstream primer, and adding a restriction site and a protection base of a restriction enzyme KpnI to a downstream primer;
GhCPK4-1F:5’-GGAATTCGTTAACAAGGATGATGATTTC-3’,SEQ ID NO:9,
GhCPK4-1R:5’-GGGGTACCGCTATTACCCGTAAAGCCAT-3’,SEQ ID NO:10。
extracting total RNA of upland cotton TM-1, carrying out reverse transcription to obtain cDNA, carrying out PCR amplification by using a primer pair consisting of a primer GhCPK4-1F and a primer GhCPK4-1R and taking the cDNA as a template to obtain a PCR amplification product.
The PCR amplification system is as follows:
PCR amplification procedure: 2min at 95 ℃; 35 cycles of 95 ℃ for 20s, 52 ℃ for 30s, 72 ℃ for 30 s; 5min at 72 ℃.
PCR amplifies the target sequence (about 488 bp); the amplification product was subjected to 1% agarose gel electrophoresis.
(2) Obtaining recombinant expression vector after sequencing
PCR amplification products were recovered from the gel, ligated with pEASY-Blunt Zero Cloning Kit (Cloning vector), and positive transformants identified by PCR using GhCPK4-1F/R primers were sequenced.
Selecting a positive transformant with successful sequencing to extract a plasmid, and carrying out double enzyme digestion on the plasmid and an empty vector pTRV2 by using enzymes EcoRI and KpnI respectively under the condition of water bath at 37 ℃, wherein the enzyme digestion system is as follows:
enzyme digestion program: 1h at 37 ℃; 10min at 80 ℃.
Carrying out 1% agarose gel electrophoresis on the enzyme digestion product, utilizing T4 DNA ligase to carry out connection, transforming agrobacterium GV3101 by the plant expression vector recombinant plasmid TRV2-GhCPK4, and obtaining the VIGS interference vector TRV2: GhCPK4 after PCR screening and identification by using GhCPK4-1F/R primer.
2. Obtaining transgenic cotton
(1) Culture of bacterial liquid
Agrobacterium was transformed with pTRV1 and TRV2-GhCPK4, respectively, to kanamycin (50. mu.g. mL) -1 ) Gentamicin (50. mu.g. mL) -1 ) And rifampicin (25. mu.g.mL) -1 ) Resistant LB flasks were grown to OD at 28 ℃ 600 Reaching 0.6-0.8.
(2) Obtaining a resuspension
Centrifuging at 4000rpm for 5min to collect thallus cells, and adding resuspension (formula: 10 mmol. L) -1 MgCl 2 ,10mmol·L -1 MES and 200. mu. mol. L -1 Acetosyringone) was resuspended to a final concentration of OD 600 Is 1.5. Standing the re-suspension at room temperature in dark place for more than 3 h. Obtaining recombinant plasmid TRV2-GhCPK 4. Resuspension containing pTRV1 vector, resuspension of TRV2-GhCLA1 vector containing GhCLA 1gene fragment, and resuspension containing TRV2 empty vector were prepared in a similar manner.
Uniformly mixing a heavy suspension containing pTRV1 vector and a heavy suspension containing a recombinant plasmid TRV2-GhCPK4 containing a target gene fragment according to the volume ratio of 1:1 to obtain a TRV/GhCPK 4 solution, and injecting the TRV/GhCPK 4 solution into cotton cotyledons to obtain a gene silencing transformant; uniformly mixing the resuspension containing the pTRV1 vector and the resuspension containing the TRV2-GhCLA1 vector containing the GhCLA 1gene fragment according to the volume ratio of 1:1 to obtain a TRV: GhCLA1 solution, and injecting the TRV: GhCLA1 solution into cotton cotyledons for detecting whether a gene silencing system is correct or not; and mixing the heavy suspension containing the pTRV1 vector and the heavy suspension containing the pTRV2 empty vector according to the volume ratio of 1:1 to obtain a TRV:00 solution, and injecting the TRV:00 solution into cotton cotyledons to serve as a genetic transformation control strain.
(3) Receptor culture
Soaking TM-1 cotton seeds in water for 24h, sowing in nutrient soil, and culturing under illumination at 26-28 deg.C for 12h in light/12 h in dark. Keeping humidity at 60% or above, watering once for 4-5 days, and performing VIGS operation when two leaves are spread and true leaves are not developed.
(4) Acquisition of GhCPK4 Gene-silenced transformant
Slightly puncturing the back of the cotyledon by using a syringe needle to cause micro-wound, and injecting the prepared re-suspension prepared in the step (2) and uniformly mixed according to the volume ratio of 1:1 from the wound by using the syringe needle to obtain the cotton GhCPK4 gene silencing transformant. And (3) keeping out of the light for 24h, and culturing under the light at the temperature of 26-28 ℃ in 12h light/12 h dark.
The ghcell 1gene silencing test strain and pTRV2 empty vector genetic transformation control strain were obtained in a similar manner.
Agrobacteria VIGS specific method reference: gao, X.Shan, L.functional genetic analysis of cotton genes with an Agrobacterium-mediated gene cloning Methods Mol Biol 2013,975: 157-.
3. Detection of VIGS genetic transformation System
(1) The phenotype of the different treated cotton was observed after 2 weeks and the VIGS system assay was performed using the upland cotton ghcia 1gene (cloroplasts alterados 1gene) as marker gene. The gene participates in the development process of the chlorophyll body, encodes 1-deoxyxylulose 5-phosphate synthsase protein, is highly conserved in evolution, and cotton plants have obvious albino phenotype after the GhCLA 1gene is silenced, so that the gene is easy to identify marker characters. As shown in FIG. 6, after 2 weeks of VIGS infection, the true leaves of the TRV1 and TRV2-GhCLA1 injected plants almost completely whitened (FIG. 6A), while the leaves injected with the empty vectors pTRV1 and pTRV2 as controls (TRV:00) did not change (FIG. 6B TRV: 00). The successful establishment of the TRV-mediated VIGS system in Gossypium hirsutum TM-1 is demonstrated.
(2) Fluorescent quantitative Real time-PCR detection
Extracting RNA (preferably a new long true leaf) from the treated cotton leaf, then carrying out qRT-PCR, detecting whether the target gene is reduced in expression or not, and detecting the expression condition of the target gene. 30 individuals were treated for each material.
And extracting total RNA of the VIGS-impregnated cotton plant leaves by using an RNA extraction kit. And detecting the interfered and silenced expression condition of the silenced GhCPK4 gene by using cotton UBQ7 as an internal reference gene and through fluorescent quantitative Real time-PCR.
Primers and PCR reaction procedure for qRT-PCR analysis in reference to section 1 of example 2, "tissue expression Pattern of Gene GhCPPK 4 in nature".
The qRT-PCR result is shown in figure 7, compared with the empty vector (TRV:00) control, the expression level of the GhCPK4 gene is obviously reduced and the silencing effect is obvious in randomly selected GhCPK4 gene VIGS-impregnated plants.
4. Cotton verticillium wilt resistance inoculation and resistance identification
(1) Inoculation of verticillium wilt of cotton
Activating the stored verticillium dahliae strain V991 which is a pathogen of verticillium wilt on a PDA culture medium. The selected thalli are cultured in Czapek, s culture solution for 3-5 d at 25 ℃ and 200 rpm. Filtering the culture solution of pathogenic bacteria with 4 layers of gauze, counting the concentration of pathogenic bacteria with a blood count plate, and adjusting the final concentration to 1.0 × 10 with sterilized double distilled water 7 spores/mL, and Tween-20 was added to a final concentration of 0.001% (volume percent). The resulting transformant in which the VIGS gene was silenced for 2 weeks was inoculated by the root injury methodVerticillium dahliae V991 spore liquid.
(2) Statistics of verticillium wilt disease onset
And (5) investigating and counting the disease incidence condition of the verticillium wilt when the real leaves begin to turn yellow and wither, and counting the disease level by adopting a 0-4 level method. 30 individuals were treated for each material. Set 3 biological replicates.
Grade index statistical reference: xue Li, Zhu Long Pai, Zhang Dong Long, research progress of anti-verticillium wilt mechanism of cotton, journal of crops, 2012,38: 1553-; xu L, Zhu L F, Zhang X L.research on resistance mechanism of cotton to Verticillium wilt.acta Agron Sin 2012,38: 1553-.
Disease index ═ number of diseased plants at each stage x corresponding disease stage)/number of total investigated plants x highest disease stage of disease (4) ] x 100
And (4) statistics of test results: compared with a control (TRV:00) plant with an empty carrier, a silencing plant of TRV: GhCPK4 infected with VIGS for 2 weeks is inoculated with verticillium dahliae strain V991, and the verticillium wilt is caused after 21 d. As can be seen in FIG. 6B, the control (TRV:00) plants showed more yellowish plaques and larger areas on the leaves and more pronounced curling down the leaf margins than the GhCPK4 gene-silenced plants. Through statistical analysis of 3 biological repeated observations, the disease index results are shown in figure 8, the average disease index of the control plants injected with the empty vectors reaches 52%, while the disease resistance of the plants subjected to GhCPK4 gene silencing is remarkably enhanced, and the average disease index is 27%. The GhCPK4 gene is shown to participate in the allergic reaction induced by verticillium wilt. After the GhCPK4 gene is silenced in upland cotton TM-1, the morbidity and the disease indication of cotton are obviously reduced when the cotton is infected by verticillium wilt bacteria, which shows that the resistance of the cotton to the verticillium wilt is improved by the silencing of the GhCPK4 gene.
(3) Verification that GhCPK4 gene participates in verticillium wilt induced anaphylactic reaction
In order to verify the accuracy of the phenotype results, the research continues to perform a verticillium wilt recovery culture experiment, diseased plant stem cutting treatment and plant verticillium wilt DNA relative abundance detection.
The experimental method for recovering and culturing verticillium dahliae comprises the following steps: cutting stems of cotton seedlings 21d after verticillium wilt treatment and 6cm away from cotyledons into 1cm long segments by using scissors, soaking the segments in 70% alcohol for 1min, soaking the segments in 30% hydrogen peroxide for 30min, washing the segments with sterile water for 4-5 times, and finally placing the treated cotton stem segments on a PDA culture medium for culture at 25 ℃ for 2d to observe the growth condition of verticillium wilt recovery culture.
The method for treating the diseased plant dissected stems comprises the following steps: taking a plurality of cotton stalks which are inoculated with verticillium wilt bacteria for 21d, longitudinally cutting the cotton stalks by using a sharp blade to expose longitudinal sections of the cotton stalks, observing the phenotype of vascular bundle tissues of the stalks, wherein if the vascular bundle tissues of the stalks are brown, the cotton stalks are infected with the verticillium wilt bacteria and are attacked, and if the vascular bundle tissues of the stalks are not brown and the phenotype is normal, the cotton stalks are not attacked.
The relative abundance method of the verticillium wilt bacteria DNA of the plant comprises the following steps: and extracting RNA of the stem of the cotton seedling after the verticillium wilt treatment, reversing the RNA into cDNA, and performing qPCR amplification.
The primers used were:
ITS1-F:5’-AAAGTTTTAATGGTTCGCTAAGA-3’,SEQ ID NO:11;
ST-VE1-R:5’-CTTGGTCATTTAGAGGAAGTAA-3’,SEQ ID NO:12。
reverse transcription and qPCR reaction procedure conditions and procedures reference example 2 section 1 "tissue expression pattern of the gene GhCPK4 in nature".
The experimental results are shown in the attached figures 9-12, and after the stems are longitudinally cut, the stem vascular bundles of the control plant injected with the empty carrier are changed into light brown, while the stem vascular bundles of the plant subjected to GhCPK4 gene silencing are normal in color, and the browning degree of the stem cutting material of the plant material with the TRV: GhCPK4 is lower than that of the control plant material with the TRV:00 injected with the empty carrier (shown in the attached figure 9); the verticillium wilt germ colony of TRV: GhCPK4 plant material cultured in PDA culture medium is less than that of TRV:00 plant material (figure 10); the verticillium wilt recovery rate of TRV:00 control plants reaches 90%, and the verticillium wilt recovery rate of plants after TRV: GhCPK4 gene silencing reaches 30% (shown in figure 11). The relative abundance of verticillium wilt bacteria DNA of TRV:00 plants is 76 times that of TRV: GhCPK4 plants after gene silencing (figure 12).
These results also indicate that cotton resistance to verticillium wilt bacteria is improved after silencing the GhCPK4 gene, indicating that the GhCPK4 gene is involved in regulating verticillium wilt resistance.
In the present specification, the embodiments are described in a progressive manner, each embodiment focuses on differences from other embodiments, and the same and similar parts among the embodiments are referred to each other.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Sequence listing
<110> institute of Nuclear technology and Biotechnology of academy of agricultural sciences in Xinjiang (center for Biotechnology research in autonomous region of Uygur autonomous region in Xinjiang)
<120> application of calcium-dependent protein kinase gene GhCPK4 in plant verticillium wilt resistance
<160> 12
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1707
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
atgggcaata catgccgtgg atctttaaag gggaaacttc ataagggcga caatcagccc 60
aaagaccatt gttctagccg caacaacact tcttccggcc gttcaaccac caccaccgat 120
tattcccctt ctactttaaa ctctcaacaa ctgattgctc aagaattctc caaagaaacc 180
aaccaaaaag aaacccattt tcctgtcatt aaccctacca agaaagacaa caacaataac 240
accatgagac gtggtattga tcaccaggct tactatgttt tgggtcataa aacacccaac 300
atccgtgacc tttacacttt aggtcgtaag ttaggacaag gacagtttgg gactacttac 360
ttgtgtactg agatctctac aggcactgag tatgcctgta agtctatatc caaaaggaag 420
ttgatctcca atgaggatgt ggaggatgtt cggagggaga ttcagataat gcaccatttg 480
gctggtcata agaatattgt gaccattaaa ggtgcatacg aggatacttt gtatgtgcat 540
attgtgatgg agctttgctc tggaggtgaa ttgtttgatc ggattatcca gagggggcat 600
tactccgaga ggaaagcagc tgaattgact aagatcattg ttggggttgt cgaggcttgt 660
cattcgctcg gggttatgca tagagattta aagcctgaga atttcttgtt agttaacaag 720
gatgatgatt tctctctgaa ggccattgat tttggactct cagtcttctt taaacccggc 780
caagttttta ccgacgtggt tggcagtcca tattacgttg ctccggaagt acttctgaaa 840
cattatggac cagaagcaga tgtatggact gcaggagtta tactctatat attgctaagt 900
ggtgtgccac cattttgggc agaaacacag caaggaatat ttgatgcagt gttaaaagga 960
catattgact ttgattcaga cccttggccc ctaatatctg atagtgcaaa agacctaatt 1020
cgaaagatgt tatgctctcg accttcagag cgactgactg ctcatgaagt attatgtcat 1080
ccttggattt gtgaaaatgg ggttgctcct gatagggccc tggatccagc tgtactttct 1140
cgcctcaaac aattctctgc aatgaataaa ctaaagaaga tggctttacg ggtaatagct 1200
gaaagtcttt ctgaggagga gattgctggt ttaagagaaa tgtttacgtc tatggatact 1260
gataacagtg gtgcaatcac atttgatgaa ctcaaagctg gtttgcgaag atacggctct 1320
accttgaaag atacagagat aagggacctt atggatgcag ctgatgtcga taatagtggg 1380
accattgatt atggagaatt catagctgca acagttcacc ttaataaact agagcgtgag 1440
gagcatctcg ttgctgcatt ccgatacttt gataaggatg gaagtgggta tattacagtt 1500
gatgagcttc aacaagcttg tgctgagcat aacatgacag atgttttgct cgaggatata 1560
atcagagaag ttgatcaaga taatgatgga agaatcgatt atggtgaatt tgttgccatg 1620
atgcaaaaag gcaatgcagg aatcggtaga cgaaccatgc gaaacagtgt gaatataagc 1680
atgagagatg ccccaggtgc tatgtaa 1707
<210> 2
<211> 568
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 2
Met Gly Asn Thr Cys Arg Gly Ser Leu Lys Gly Lys Leu His Lys Gly
1 5 10 15
Asp Asn Gln Pro Lys Asp His Cys Ser Ser Arg Asn Asn Thr Ser Ser
20 25 30
Gly Arg Ser Thr Thr Thr Thr Asp Tyr Ser Pro Ser Thr Leu Asn Ser
35 40 45
Gln Gln Leu Ile Ala Gln Glu Phe Ser Lys Glu Thr Asn Gln Lys Glu
50 55 60
Thr His Phe Pro Val Ile Asn Pro Thr Lys Lys Asp Asn Asn Asn Asn
65 70 75 80
Thr Met Arg Arg Gly Ile Asp His Gln Ala Tyr Tyr Val Leu Gly His
85 90 95
Lys Thr Pro Asn Ile Arg Asp Leu Tyr Thr Leu Gly Arg Lys Leu Gly
100 105 110
Gln Gly Gln Phe Gly Thr Thr Tyr Leu Cys Thr Glu Ile Ser Thr Gly
115 120 125
Thr Glu Tyr Ala Cys Lys Ser Ile Ser Lys Arg Lys Leu Ile Ser Asn
130 135 140
Glu Asp Val Glu Asp Val Arg Arg Glu Ile Gln Ile Met His His Leu
145 150 155 160
Ala Gly His Lys Asn Ile Val Thr Ile Lys Gly Ala Tyr Glu Asp Thr
165 170 175
Leu Tyr Val His Ile Val Met Glu Leu Cys Ser Gly Gly Glu Leu Phe
180 185 190
Asp Arg Ile Ile Gln Arg Gly His Tyr Ser Glu Arg Lys Ala Ala Glu
195 200 205
Leu Thr Lys Ile Ile Val Gly Val Val Glu Ala Cys His Ser Leu Gly
210 215 220
Val Met His Arg Asp Leu Lys Pro Glu Asn Phe Leu Leu Val Asn Lys
225 230 235 240
Asp Asp Asp Phe Ser Leu Lys Ala Ile Asp Phe Gly Leu Ser Val Phe
245 250 255
Phe Lys Pro Gly Gln Val Phe Thr Asp Val Val Gly Ser Pro Tyr Tyr
260 265 270
Val Ala Pro Glu Val Leu Leu Lys His Tyr Gly Pro Glu Ala Asp Val
275 280 285
Trp Thr Ala Gly Val Ile Leu Tyr Ile Leu Leu Ser Gly Val Pro Pro
290 295 300
Phe Trp Ala Glu Thr Gln Gln Gly Ile Phe Asp Ala Val Leu Lys Gly
305 310 315 320
His Ile Asp Phe Asp Ser Asp Pro Trp Pro Leu Ile Ser Asp Ser Ala
325 330 335
Lys Asp Leu Ile Arg Lys Met Leu Cys Ser Arg Pro Ser Glu Arg Leu
340 345 350
Thr Ala His Glu Val Leu Cys His Pro Trp Ile Cys Glu Asn Gly Val
355 360 365
Ala Pro Asp Arg Ala Leu Asp Pro Ala Val Leu Ser Arg Leu Lys Gln
370 375 380
Phe Ser Ala Met Asn Lys Leu Lys Lys Met Ala Leu Arg Val Ile Ala
385 390 395 400
Glu Ser Leu Ser Glu Glu Glu Ile Ala Gly Leu Arg Glu Met Phe Thr
405 410 415
Ser Met Asp Thr Asp Asn Ser Gly Ala Ile Thr Phe Asp Glu Leu Lys
420 425 430
Ala Gly Leu Arg Arg Tyr Gly Ser Thr Leu Lys Asp Thr Glu Ile Arg
435 440 445
Asp Leu Met Asp Ala Ala Asp Val Asp Asn Ser Gly Thr Ile Asp Tyr
450 455 460
Gly Glu Phe Ile Ala Ala Thr Val His Leu Asn Lys Leu Glu Arg Glu
465 470 475 480
Glu His Leu Val Ala Ala Phe Arg Tyr Phe Asp Lys Asp Gly Ser Gly
485 490 495
Tyr Ile Thr Val Asp Glu Leu Gln Gln Ala Cys Ala Glu His Asn Met
500 505 510
Thr Asp Val Leu Leu Glu Asp Ile Ile Arg Glu Val Asp Gln Asp Asn
515 520 525
Asp Gly Arg Ile Asp Tyr Gly Glu Phe Val Ala Met Met Gln Lys Gly
530 535 540
Asn Ala Gly Ile Gly Arg Arg Thr Met Arg Asn Ser Val Asn Ile Ser
545 550 555 560
Met Arg Asp Ala Pro Gly Ala Met
565
<210> 3
<211> 27
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
ggggtaccat gggcaataca tgccgtg 27
<210> 4
<211> 27
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
gctctagatt acatagcacc tggggca 27
<210> 5
<211> 21
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
gttaacaagg atgatgattt c 21
<210> 6
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
<210> 7
<211> 22
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 7
gaaggcattc cacctgacca ac 22
<210> 8
<211> 25
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 8
cttgaccttc ttcttcttgt gcttg 25
<210> 9
<211> 28
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 9
ggaattcgtt aacaaggatg atgatttc 28
<210> 10
<211> 28
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 10
ggggtaccgc tattacccgt aaagccat 28
<210> 11
<211> 23
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 11
aaagttttaa tggttcgcta aga 23
<210> 12
<211> 22
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 12
cttggtcatt tagaggaagt aa 22
Claims (8)
1. The application of protein or substance for regulating and controlling the expression of protein coding gene in plant verticillium wilt resistance is characterized in that the amino acid sequence of the protein is shown as SEQ ID NO: 2 is shown in the specification;
or in the SEQ ID NO: 2, the N terminal and/or the C terminal of the amino acid sequence is linked with a protein tag to obtain a fusion protein;
or converting said SEQ ID NO: 2 by substitution and/or deletion and/or addition of more than one amino acid residue, and obtaining the protein with the same function.
2. Use according to claim 1, wherein the protein is derived from cotton.
3. Use of a protein-related biological material as claimed in claim 1 or 2 for combating verticillium wilt in plants, wherein the material is any one of the following:
a: a nucleic acid molecule encoding the protein of claim 1;
b: an expression cassette comprising silencing of the nucleic acid molecule of A;
c: an expression vector containing the nucleic acid molecule A or a recombinant vector containing the expression cassette B;
d: a recombinant microorganism comprising the nucleic acid molecule described in A, or a recombinant microorganism comprising the expression cassette described in B, or a recombinant microorganism comprising the recombinant vector described in C.
4. The use according to claim 3, wherein the nucleic acid molecule has the nucleotide sequence set forth in SEQ ID NO: 1 is shown in the specification;
or with said SEQ ID NO: 1 nucleotide sequence having more than 90% homology and encoding the protein of claim 1.
5. The use according to any one of claims 1 to 4, wherein the plant is any one of the following:
a: a plant of the genus gossypium; b: cotton; c: 1, upland cotton TM-1.
6. A method for improving verticillium wilt resistance in plants, which comprises silencing or inhibiting the expression level of a gene encoding the protein of claim 1 or the activity of the protein of claim 1 in plants to thereby improve verticillium wilt resistance.
7. The method of claim 6, wherein the amino acid sequence of the protein is as set forth in SEQ ID NO: 2, respectively.
8. The method of claim 6, wherein the nucleotide sequence of the gene encoding the protein is as set forth in SEQ ID NO: 1 is shown.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210514664.4A CN114790449B (en) | 2022-05-11 | 2022-05-11 | Application of calpain gene GhCPK4 in verticillium resistance of plants |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210514664.4A CN114790449B (en) | 2022-05-11 | 2022-05-11 | Application of calpain gene GhCPK4 in verticillium resistance of plants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114790449A true CN114790449A (en) | 2022-07-26 |
| CN114790449B CN114790449B (en) | 2023-08-01 |
Family
ID=82462987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210514664.4A Active CN114790449B (en) | 2022-05-11 | 2022-05-11 | Application of calpain gene GhCPK4 in verticillium resistance of plants |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114790449B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115820722A (en) * | 2022-07-28 | 2023-03-21 | 新疆农业科学院核技术生物技术研究所(新疆维吾尔自治区生物技术研究中心) | Cotton verticillium wilt resistance related gene GhCBL3 and coding protein and application thereof |
| CN116334023A (en) * | 2022-11-07 | 2023-06-27 | 新疆农业科学院核技术生物技术研究所(新疆维吾尔自治区生物技术研究中心) | Application of Calcium-Dependent Protein Kinase Gene GhCDPK29 in Plant Resistance to Verticillium Wilt |
| CN116536347A (en) * | 2023-03-31 | 2023-08-04 | 新疆农业科学院核技术生物技术研究所(新疆维吾尔自治区生物技术研究中心) | Application of calcium-dependent protein kinase gene GhCAMK in verticillium wilt resistance of plants |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060206958A1 (en) * | 2001-06-22 | 2006-09-14 | Keygene N.V. | Nucleotide sequences involved in plant disease resistance |
| WO2007100238A1 (en) * | 2006-02-28 | 2007-09-07 | Keygene N.V. | Disease resistant plants |
| US20090123999A1 (en) * | 2006-02-28 | 2009-05-14 | Keygene N.V. | Nucleotide sequences invovled in plant disease resistance |
| CN102108364A (en) * | 2009-12-24 | 2011-06-29 | 上海市农业科学院 | Salt-resistant and drought-resistant CPK (creatine phosphokinase) protein kinase gene derived from arabidopsis thaliana |
| CN105838726A (en) * | 2016-05-13 | 2016-08-10 | 哈尔滨师范大学 | Alfalfa salt tolerance gene MsCDPK and encoded protein and application thereof |
| CN107586782A (en) * | 2017-10-09 | 2018-01-16 | 南京农业大学 | It is a kind of by disturbing verticillium wilt pathogen VdRGS1 gene expressions to significantly improve method of the cotton to resistance to verticillium wilt |
| CN109112149A (en) * | 2018-02-12 | 2019-01-01 | 华中农业大学 | Regulate and control cotton Calcium-dependent protein kinase GhCPK33 gene and the application of cotton verticillium wilt resistance |
| CN112322628A (en) * | 2020-09-27 | 2021-02-05 | 湖北大学 | Transcription factor GhWRKY1-like gene for regulating and controlling verticillium wilt and drought resistance of cotton and application thereof |
| CN112390868A (en) * | 2020-11-30 | 2021-02-23 | 江苏科技大学 | Mulberry calmodulin protein MmCML37 and application thereof |
-
2022
- 2022-05-11 CN CN202210514664.4A patent/CN114790449B/en active Active
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060206958A1 (en) * | 2001-06-22 | 2006-09-14 | Keygene N.V. | Nucleotide sequences involved in plant disease resistance |
| WO2007100238A1 (en) * | 2006-02-28 | 2007-09-07 | Keygene N.V. | Disease resistant plants |
| US20090123999A1 (en) * | 2006-02-28 | 2009-05-14 | Keygene N.V. | Nucleotide sequences invovled in plant disease resistance |
| CN102108364A (en) * | 2009-12-24 | 2011-06-29 | 上海市农业科学院 | Salt-resistant and drought-resistant CPK (creatine phosphokinase) protein kinase gene derived from arabidopsis thaliana |
| CN105838726A (en) * | 2016-05-13 | 2016-08-10 | 哈尔滨师范大学 | Alfalfa salt tolerance gene MsCDPK and encoded protein and application thereof |
| CN107586782A (en) * | 2017-10-09 | 2018-01-16 | 南京农业大学 | It is a kind of by disturbing verticillium wilt pathogen VdRGS1 gene expressions to significantly improve method of the cotton to resistance to verticillium wilt |
| CN109112149A (en) * | 2018-02-12 | 2019-01-01 | 华中农业大学 | Regulate and control cotton Calcium-dependent protein kinase GhCPK33 gene and the application of cotton verticillium wilt resistance |
| CN112322628A (en) * | 2020-09-27 | 2021-02-05 | 湖北大学 | Transcription factor GhWRKY1-like gene for regulating and controlling verticillium wilt and drought resistance of cotton and application thereof |
| CN112390868A (en) * | 2020-11-30 | 2021-02-23 | 江苏科技大学 | Mulberry calmodulin protein MmCML37 and application thereof |
Non-Patent Citations (9)
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115820722A (en) * | 2022-07-28 | 2023-03-21 | 新疆农业科学院核技术生物技术研究所(新疆维吾尔自治区生物技术研究中心) | Cotton verticillium wilt resistance related gene GhCBL3 and coding protein and application thereof |
| CN116334023A (en) * | 2022-11-07 | 2023-06-27 | 新疆农业科学院核技术生物技术研究所(新疆维吾尔自治区生物技术研究中心) | Application of Calcium-Dependent Protein Kinase Gene GhCDPK29 in Plant Resistance to Verticillium Wilt |
| CN116536347A (en) * | 2023-03-31 | 2023-08-04 | 新疆农业科学院核技术生物技术研究所(新疆维吾尔自治区生物技术研究中心) | Application of calcium-dependent protein kinase gene GhCAMK in verticillium wilt resistance of plants |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114790449B (en) | 2023-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN116334023B (en) | Application of calpain gene GhCDPK in verticillium resistance of plants | |
| CN114790449B (en) | Application of calpain gene GhCPK4 in verticillium resistance of plants | |
| CN117965567B (en) | Application of cotton GhRV gene in negative control of verticillium resistance | |
| CN115161332B (en) | Vitis spinosa VdERF2 gene and encoding protein and application thereof | |
| CN110862996B (en) | Application of isolated soybean gene in improving soybean cyst nematode resistance | |
| CN110872598B (en) | Cotton drought-resistant related gene GhDT1 and application thereof | |
| CN117568289A (en) | Protein for resisting soybean cyst nematode disease, encoding gene and application thereof | |
| Mao et al. | Overexpression of cotton Trihelix transcription factor GhGT-3b_A04 enhances resistance to Verticillium dahliae and affects plant growth in Arabidopsis thaliana | |
| CN106554964B (en) | Application of cotton GbABR1 gene in verticillium wilt resistance | |
| CN111500579A (en) | Cotton miR164a and NAC 100L and application thereof in regulation and control of verticillium wilt resistance of plants | |
| CN115976052B (en) | Wheat stem rot resistance gene TaHSP18.6, its expression product, recombinant vector and application | |
| CN107674875B (en) | Application of cotton GbCaMBP gene in plant verticillium wilt resistance | |
| CN103451225B (en) | Application of rice WRKY transcription factor gene OsWRKY21 in cultivation of resistant varieties of plants | |
| CN118853755B (en) | Application of upland cotton GhBGH gene in regulation and control of salt tolerance of cotton | |
| CN101492498B (en) | Plant stress resistance-related protein and its coding gene TaERECTA and its application | |
| CN109207485B (en) | Application of OsAPS1 gene in improving disease resistance of rice | |
| CN106434694B (en) | Application of cotton GbDREB gene in verticillium wilt resistance | |
| CN103243110B (en) | Anti-magnaporthe oryzae paddy gene OsWRKY19 and application thereof | |
| CN103789324A (en) | Rice OsMOS4 gene capable of improving rice blast resistance and application of gene | |
| CN116536347B (en) | Application of calpain gene GhCCAMK in verticillium resistance of plants | |
| CN112592392A (en) | Application of pleiotropic gene SbSnf4 in improvement of cane sugar yield, plant height, fresh weight of stems and/or juice amount | |
| CN121406670B (en) | Use of CpWRKY71 related biological products in regulating and controlling powdery mildew resistance of pumpkin | |
| CN119662713B (en) | Application and method of tea plant CsETR2 gene in improving plant disease resistance | |
| CN120795110B (en) | Plant disease resistance related protein TaCNGC, coding gene and application thereof | |
| CN113528558B (en) | Application of Gene GhSINAs in Controlling Cotton Verticillium Wilt |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |




